Charles Schwab Investment Management Inc. Purchases 38,810 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Charles Schwab Investment Management Inc. boosted its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 5.3% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 772,746 shares of the company’s stock after buying an additional 38,810 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.61% of Surgery Partners worth $24,913,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. KBC Group NV grew its position in shares of Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its stake in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after purchasing an additional 1,375 shares during the last quarter. Quarry LP lifted its stake in Surgery Partners by 133.1% in the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares during the last quarter. Creative Planning bought a new position in Surgery Partners in the 3rd quarter valued at approximately $258,000. Finally, Versor Investments LP bought a new position in shares of Surgery Partners during the third quarter valued at $271,000.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $21.46 on Friday. The firm has a market cap of $2.73 billion, a price-to-earnings ratio of -44.71, a P/E/G ratio of 19.15 and a beta of 2.58. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. Surgery Partners, Inc. has a 52 week low of $21.10 and a 52 week high of $36.92. The firm’s 50-day simple moving average is $28.20 and its two-hundred day simple moving average is $28.12.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. During the same period last year, the firm earned $0.15 EPS. The business’s revenue for the quarter was up 14.3% on a year-over-year basis. As a group, equities analysts forecast that Surgery Partners, Inc. will post 0.73 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on SGRY shares. Macquarie reaffirmed an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. Benchmark restated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a report on Monday, August 26th. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a report on Friday, October 4th. Royal Bank of Canada reduced their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $37.38.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.